Aurobindo Pharma has announced changes in its senior management. Dr. Mandepudi Sudhakara Reddy, Associate President, Corporate QA, has resigned, effective November 4, 2025. Additionally, Mr. K. P. Ravinatha Shetty, President, Operations, has retired from the company as of November 3, 2025, upon reaching superannuation.
Senior Management Update
Aurobindo Pharma has confirmed key personnel changes within its senior leadership team. These changes involve both a resignation and a retirement, impacting the company’s Corporate QA and Operations divisions.
Resignation of Dr. Mandepudi Sudhakara Reddy
Dr. Mandepudi Sudhakara Reddy, who held the position of Associate President, Corporate QA, tendered his resignation on August 9, 2025. Aurobindo Pharma has accepted his resignation, which will be effective from the close of business hours on November 4, 2025.
Retirement of Mr. K. P. Ravinatha Shetty
Mr. K. P. Ravinatha Shetty, serving as President, Operations, has retired from Aurobindo Pharma, effective November 3, 2025. His retirement is due to attaining superannuation.
Source: BSE
